Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank

The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic protein-cancer risk associations. We investigated associations of 1463 plasma proteins with incidence of 19 cancers and 9 cancer subsites in UK Bioban...

Full description

Saved in:

Bibliographic Details
Published in	Nature communications Vol. 15; no. 1; pp. 4010 - 12
Main Authors	Papier, Keren, Atkins, Joshua R., Tong, Tammy Y. N., Gaitskell, Kezia, Desai, Trishna, Ogamba, Chibuzor F., Parsaeian, Mahboubeh, Reeves, Gillian K., Mills, Ian G., Key, Tim J., Smith-Byrne, Karl, Travis, Ruth C.
Format	Journal Article
Language	English
Published	London Nature Publishing Group UK 15.05.2024 Nature Publishing Group Nature Portfolio
Subjects	45/43 692/4028 692/499 82/81 ADAM8 protein Aged Biobanks Biological Specimen Banks Blood Blood Proteins - genetics Cancer Diagnosis Exome - genetics Exome Sequencing Female Genetic analysis Genetic Predisposition to Disease Health risks Humanities and Social Sciences Humans Incidence Leukemia Lung cancer Male Middle Aged multidisciplinary Neoplasms - blood Neoplasms - epidemiology Neoplasms - genetics Plasma proteins Prospective Studies Proteins Proteomics Risk Factors Science Science (multidisciplinary) UK Biobank United Kingdom - epidemiology United Kingdom United Kingdom > UK
Online Access	Get full text
ISSN	2041-1723 2041-1723
DOI	10.1038/s41467-024-48017-6

Cover

Abstract	The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic protein-cancer risk associations. We investigated associations of 1463 plasma proteins with incidence of 19 cancers and 9 cancer subsites in UK Biobank participants (average 12 years follow-up). Emerging protein-cancer associations were further explored using two genetic approaches, cis -pQTL and exome-wide protein genetic scores (exGS). We identify 618 protein-cancer associations, of which 107 persist for cases diagnosed more than seven years after blood draw, 29 of 618 were associated in genetic analyses, and four had support from long time-to-diagnosis ( > 7 years) and both cis -pQTL and exGS analyses: CD74 and TNFRSF1B with NHL, ADAM8 with leukemia, and SFTPA2 with lung cancer. We present multiple blood protein-cancer risk associations, including many detectable more than seven years before cancer diagnosis and that had concordant evidence from genetic analyses, suggesting a possible role in cancer development. Plasma proteins are a potential diagnostic tool to detect multiple diseases, including cancer. Here, the authors leverage multi-omics data to identify 1,463 proteins associated with 19 common cancers in UK Biobank participants. Reviewer Recognition:
AbstractList	The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic protein-cancer risk associations. We investigated associations of 1463 plasma proteins with incidence of 19 cancers and 9 cancer subsites in UK Biobank participants (average 12 years follow-up). Emerging protein-cancer associations were further explored using two genetic approaches, cis -pQTL and exome-wide protein genetic scores (exGS). We identify 618 protein-cancer associations, of which 107 persist for cases diagnosed more than seven years after blood draw, 29 of 618 were associated in genetic analyses, and four had support from long time-to-diagnosis ( > 7 years) and both cis -pQTL and exGS analyses: CD74 and TNFRSF1B with NHL, ADAM8 with leukemia, and SFTPA2 with lung cancer. We present multiple blood protein-cancer risk associations, including many detectable more than seven years before cancer diagnosis and that had concordant evidence from genetic analyses, suggesting a possible role in cancer development. Plasma proteins are a potential diagnostic tool to detect multiple diseases, including cancer. Here, the authors leverage multi-omics data to identify 1,463 proteins associated with 19 common cancers in UK Biobank participants. Reviewer Recognition: The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic protein-cancer risk associations. We investigated associations of 1463 plasma proteins with incidence of 19 cancers and 9 cancer subsites in UK Biobank participants (average 12 years follow-up). Emerging protein-cancer associations were further explored using two genetic approaches, cis-pQTL and exome-wide protein genetic scores (exGS). We identify 618 protein-cancer associations, of which 107 persist for cases diagnosed more than seven years after blood draw, 29 of 618 were associated in genetic analyses, and four had support from long time-to-diagnosis ( > 7 years) and both cis-pQTL and exGS analyses: CD74 and TNFRSF1B with NHL, ADAM8 with leukemia, and SFTPA2 with lung cancer. We present multiple blood protein-cancer risk associations, including many detectable more than seven years before cancer diagnosis and that had concordant evidence from genetic analyses, suggesting a possible role in cancer development.Plasma proteins are a potential diagnostic tool to detect multiple diseases, including cancer. Here, the authors leverage multi-omics data to identify 1,463 proteins associated with 19 common cancers in UK Biobank participants. Reviewer Recognition: The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic protein-cancer risk associations. We investigated associations of 1463 plasma proteins with incidence of 19 cancers and 9 cancer subsites in UK Biobank participants (average 12 years follow-up). Emerging protein-cancer associations were further explored using two genetic approaches, cis-pQTL and exome-wide protein genetic scores (exGS). We identify 618 protein-cancer associations, of which 107 persist for cases diagnosed more than seven years after blood draw, 29 of 618 were associated in genetic analyses, and four had support from long time-to-diagnosis ( > 7 years) and both cis-pQTL and exGS analyses: CD74 and TNFRSF1B with NHL, ADAM8 with leukemia, and SFTPA2 with lung cancer. We present multiple blood protein-cancer risk associations, including many detectable more than seven years before cancer diagnosis and that had concordant evidence from genetic analyses, suggesting a possible role in cancer development.The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic protein-cancer risk associations. We investigated associations of 1463 plasma proteins with incidence of 19 cancers and 9 cancer subsites in UK Biobank participants (average 12 years follow-up). Emerging protein-cancer associations were further explored using two genetic approaches, cis-pQTL and exome-wide protein genetic scores (exGS). We identify 618 protein-cancer associations, of which 107 persist for cases diagnosed more than seven years after blood draw, 29 of 618 were associated in genetic analyses, and four had support from long time-to-diagnosis ( > 7 years) and both cis-pQTL and exGS analyses: CD74 and TNFRSF1B with NHL, ADAM8 with leukemia, and SFTPA2 with lung cancer. We present multiple blood protein-cancer risk associations, including many detectable more than seven years before cancer diagnosis and that had concordant evidence from genetic analyses, suggesting a possible role in cancer development. The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic protein-cancer risk associations. We investigated associations of 1463 plasma proteins with incidence of 19 cancers and 9 cancer subsites in UK Biobank participants (average 12 years follow-up). Emerging protein-cancer associations were further explored using two genetic approaches, cis-pQTL and exome-wide protein genetic scores (exGS). We identify 618 protein-cancer associations, of which 107 persist for cases diagnosed more than seven years after blood draw, 29 of 618 were associated in genetic analyses, and four had support from long time-to-diagnosis ( > 7 years) and both cis-pQTL and exGS analyses: CD74 and TNFRSF1B with NHL, ADAM8 with leukemia, and SFTPA2 with lung cancer. We present multiple blood protein-cancer risk associations, including many detectable more than seven years before cancer diagnosis and that had concordant evidence from genetic analyses, suggesting a possible role in cancer development. The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic protein-cancer risk associations. We investigated associations of 1463 plasma proteins with incidence of 19 cancers and 9 cancer subsites in UK Biobank participants (average 12 years follow-up). Emerging protein-cancer associations were further explored using two genetic approaches, cis -pQTL and exome-wide protein genetic scores (exGS). We identify 618 protein-cancer associations, of which 107 persist for cases diagnosed more than seven years after blood draw, 29 of 618 were associated in genetic analyses, and four had support from long time-to-diagnosis ( > 7 years) and both cis -pQTL and exGS analyses: CD74 and TNFRSF1B with NHL, ADAM8 with leukemia, and SFTPA2 with lung cancer. We present multiple blood protein-cancer risk associations, including many detectable more than seven years before cancer diagnosis and that had concordant evidence from genetic analyses, suggesting a possible role in cancer development. Abstract The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic protein-cancer risk associations. We investigated associations of 1463 plasma proteins with incidence of 19 cancers and 9 cancer subsites in UK Biobank participants (average 12 years follow-up). Emerging protein-cancer associations were further explored using two genetic approaches, cis-pQTL and exome-wide protein genetic scores (exGS). We identify 618 protein-cancer associations, of which 107 persist for cases diagnosed more than seven years after blood draw, 29 of 618 were associated in genetic analyses, and four had support from long time-to-diagnosis ( > 7 years) and both cis-pQTL and exGS analyses: CD74 and TNFRSF1B with NHL, ADAM8 with leukemia, and SFTPA2 with lung cancer. We present multiple blood protein-cancer risk associations, including many detectable more than seven years before cancer diagnosis and that had concordant evidence from genetic analyses, suggesting a possible role in cancer development.
ArticleNumber	4010
Author	Key, Tim J. Papier, Keren Parsaeian, Mahboubeh Ogamba, Chibuzor F. Smith-Byrne, Karl Travis, Ruth C. Atkins, Joshua R. Reeves, Gillian K. Tong, Tammy Y. N. Gaitskell, Kezia Desai, Trishna Mills, Ian G.
Author_xml	– sequence: 1 givenname: Keren orcidid: 0000-0002-4102-6835 surname: Papier fullname: Papier, Keren email: keren.papier@ndph.ox.ac.uk organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford – sequence: 2 givenname: Joshua R. orcidid: 0000-0003-0821-1112 surname: Atkins fullname: Atkins, Joshua R. organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford – sequence: 3 givenname: Tammy Y. N. orcidid: 0000-0002-0284-8959 surname: Tong fullname: Tong, Tammy Y. N. organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford – sequence: 4 givenname: Kezia orcidid: 0000-0002-2474-1159 surname: Gaitskell fullname: Gaitskell, Kezia organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford – sequence: 5 givenname: Trishna surname: Desai fullname: Desai, Trishna organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford – sequence: 6 givenname: Chibuzor F. orcidid: 0000-0003-3778-311X surname: Ogamba fullname: Ogamba, Chibuzor F. organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford – sequence: 7 givenname: Mahboubeh surname: Parsaeian fullname: Parsaeian, Mahboubeh organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford – sequence: 8 givenname: Gillian K. surname: Reeves fullname: Reeves, Gillian K. organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford – sequence: 9 givenname: Ian G. orcidid: 0000-0001-5347-5083 surname: Mills fullname: Mills, Ian G. organization: Nuffield Department of Surgical Sciences, University of Oxford, Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast – sequence: 10 givenname: Tim J. orcidid: 0000-0003-2294-307X surname: Key fullname: Key, Tim J. organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford – sequence: 11 givenname: Karl orcidid: 0000-0002-1932-7463 surname: Smith-Byrne fullname: Smith-Byrne, Karl organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford – sequence: 12 givenname: Ruth C. surname: Travis fullname: Travis, Ruth C. organization: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/38750076$$D View this record in MEDLINE/PubMed
BookMark	eNp9ks1u1DAYRSNUREvpC7BAltiwCfjfzgpBxc-ISmzo2nIcZ-ppYg-2UzFvwuPiTKal7aJZJFZy7smVvu9ldeSDt1X1GsH3CBL5IVFEuaghpjWVEImaP6tOMKSoRgKTo3vn4-ospQ0sF2mQpPRFdUykYBAKflL9XXXWZ9fvnF-DbQzZhtEZEF26Br02OcQE-hCB0d7YCKZ04NLWmuxuLNC-A_ZPGOeTHnbJJhB6ULoRYFw006Dzndr5tOf39plqDt4EnAf5yoLLH-CzC63216-q570ekj07PE-ry69ffp1_ry9-fludf7qoDaMo15wThjvDONKSQGoE6iznElOte9IZiyhpBRQt11hgTBEziDGGEIQaU95AclqtFm8X9EZtoxt13Kmgndq_CHGtdMzODFaVHBamL3daspJIKxHqGoJ7xFtGZ9fHxbWd2tGWv_sc9fBA-vCLd1dqHW5U6dNwgnAxvDsYYvg92ZTV6JKxw6C9DVNSBDImG4oxKejbR-gmTLHMYKEwZYQ2hXpzv9Jdl9sNKIBcAFOGmqLtlXG5zCzMDd2gEFTzvqll31TZN7XfNzVH8aPorf3JEFlCqcB-beP_2k-k_gG_oOW3
CitedBy_id	crossref_primary_10_1016_j_tranon_2024_102059 crossref_primary_10_1007_s12672_025_01983_9 crossref_primary_10_1016_j_tranon_2024_102172 crossref_primary_10_1021_acs_jproteome_4c00773 crossref_primary_10_3390_ijms25147974 crossref_primary_10_1038_s41598_024_63399_9 crossref_primary_10_7759_cureus_75142 crossref_primary_10_1016_j_atherosclerosis_2025_119110 crossref_primary_10_1093_clinchem_hvae149 crossref_primary_10_1038_s43856_024_00671_z
Cites_doi	10.1038/s41588-022-01051-w 10.1158/0008-5472.CAN-20-1281 10.1038/s41467-018-03910-9 10.1158/1055-9965.EPI-14-1107 10.1038/s41467-019-11337-z 10.1182/blood.2021012890 10.1016/j.bbagen.2020.129834 10.3322/caac.21660 10.1093/nar/gky1075 10.1016/j.ejca.2010.09.016 10.1038/s41467-023-37979-8 10.1038/s41586-023-06547-x 10.1155/2017/4803156 10.1158/0008-5472.CAN-20-3454 10.1111/imcb.12484 10.1038/s41591-023-02420-6 10.1002/pro.3307 10.1016/j.ccell.2018.10.016 10.1038/d41586-018-01023-3 10.1038/s41586-020-2308-7 10.1182/blood-2009-08-236596 10.1021/bi1014858 10.1016/j.cell.2017.06.010 10.1002/cncr.31986 10.1093/nar/gkac1046 10.1038/s41576-020-0268-2 10.1016/j.mcpro.2021.100168 10.1038/s41467-023-39765-y 10.1093/annonc/mdz121 10.1093/ije/dyac124 10.1016/S0140-6736(21)00731-5 10.3390/cancers14133261 10.1016/S0140-6736(12)60404-8 10.1093/aje/kwx246 10.1073/pnas.1217238110 10.1016/j.annepidem.2022.10.014 10.1002/gepi.22506 10.1038/s41568-020-0290-x 10.1093/ije/dyab274 10.1038/s41586-023-06592-6 10.4161/fly.19695 10.1186/s13073-020-00755-0 10.1001/jamaoncol.2018.2078 10.3389/fimmu.2021.681639 10.1093/ije/dyw314 10.1101/2022.10.09.511476 10.1101/2023.11.13.23298365 10.1200/EDBK_390384
ContentType	Journal Article
Copyright	The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI RC3 SOI 7X8 5PM DOA
DOI	10.1038/s41467-024-48017-6
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database MEDLINE - Academic MEDLINE CrossRef
Database_xml	– sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2041-1723
EndPage	12
ExternalDocumentID	oai_doaj_org_article_55127cf5124246838e811d932f16b540 PMC11096312 38750076 10_1038_s41467_024_48017_6
Genre	Journal Article
GeographicLocations	United Kingdom United Kingdom--UK
GeographicLocations_xml	– name: United Kingdom – name: United Kingdom--UK
GrantInformation_xml	– fundername: Cancer Research UK (CRUK) grantid: C8221/A29017; C8221/A29186 funderid: https://doi.org/10.13039/501100000289 – fundername: Cancer Research UK (CRUK) grantid: C8221/A29186 – fundername: Wellcome Trust – fundername: Cancer Research UK (CRUK) grantid: C8221/A29017 – fundername: Cancer Research UK grantid: 29186 – fundername: Cancer Research UK grantid: 29017
GroupedDBID	--- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LGEZI LK8 LOTEE M1P M48 M7P M~E NADUK NAO NXXTH O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM PMFND 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AARCD AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI RC3 SOI 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c541t-66352dc561a8304c71de66824aaf3dce143b707b6a2722415c15551100a246903
IEDL.DBID	BENPR
ISSN	2041-1723
IngestDate	Wed Aug 27 01:14:12 EDT 2025 Thu Aug 21 18:35:43 EDT 2025 Fri Sep 05 14:02:24 EDT 2025 Wed Aug 13 04:33:12 EDT 2025 Sat May 31 02:13:26 EDT 2025 Tue Jul 01 02:11:07 EDT 2025 Thu Apr 24 22:59:32 EDT 2025 Fri Feb 21 02:37:21 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c541t-66352dc561a8304c71de66824aaf3dce143b707b6a2722415c15551100a246903
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-0284-8959 0000-0001-5347-5083 0000-0003-3778-311X 0000-0003-0821-1112 0000-0002-1932-7463 0000-0003-2294-307X 0000-0002-4102-6835 0000-0002-2474-1159
OpenAccessLink	https://www.proquest.com/docview/3055245349?pq-origsite=%requestingapplication%&accountid=15518
PMID	38750076
PQID	3055245349
PQPubID	546298
PageCount	12
ParticipantIDs	doaj_primary_oai_doaj_org_article_55127cf5124246838e811d932f16b540 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11096312 proquest_miscellaneous_3055894223 proquest_journals_3055245349 pubmed_primary_38750076 crossref_citationtrail_10_1038_s41467_024_48017_6 crossref_primary_10_1038_s41467_024_48017_6 springer_journals_10_1038_s41467_024_48017_6
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2024-05-15
PublicationDateYYYYMMDD	2024-05-15
PublicationDate_xml	– month: 05 year: 2024 text: 2024-05-15 day: 15
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Nature communications
PublicationTitleAbbrev	Nat Commun
PublicationTitleAlternate	Nat Commun
PublicationYear	2024
Publisher	Nature Publishing Group UK Nature Publishing Group Nature Portfolio
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio
References	Smith Byrne (CR3) 2019; 30 Chen (CR52) 2019; 10 Harlid, Myte, Van Guelpen (CR29) 2017; 2017 Fry (CR34) 2017; 186 CR36 Ochoa (CR48) 2023; 51 Dagnino (CR21) 2021; 81 Kartsonaki (CR30) 2022; 51 Wik (CR42) 2021; 20 Álvez (CR31) 2023; 14 Karczewski (CR53) 2020; 581 Zhong (CR13) 2020; 12 Lane (CR7) 2010; 46 Kolijn (CR32) 2022; 139 CR46 Zhang (CR37) 2022; 54 CR44 CR43 Tsherniak (CR17) 2017; 170 Cingolani (CR45) 2012; 6 Gerhauser (CR25) 2018; 34 Kim, Lee (CR15) 2021; 1865 Munafò, Davey Smith (CR10) 2018; 553 Sung (CR35) 2021; 71 Benton (CR20) 2019; 125 Menon (CR4) 2021; 397 Langenberg, Hingorani, Whitty (CR40) 2023; 29 Albanes (CR27) 2023; 14 Collins (CR41) 2012; 379 CR16 Wilson, Villadangos, Mintern (CR23) 2021; 99 CR14 Knuppel (CR1) 2020; 80 CR51 CR50 Dhindsa (CR39) 2023; 622 Beer (CR18) 2010; 115 Martínez-Jiménez (CR26) 2020; 20 Suhre, McCarthy, Schwenk (CR9) 2021; 22 Gnanasambandan, Magis, Sayeski (CR19) 2010; 49 Sun (CR38) 2023; 622 (CR5) 2018; 4 Gkatzionis, Burgess, Newcombe (CR12) 2023; 47 Kaaks (CR33) 2015; 24 Watts (CR2) 2023; 52 Sun (CR28) 2022; 14 DeBoever (CR11) 2018; 9 Thul, Lindskog (CR47) 2018; 27 Ballehaninna, Chamberlain (CR6) 2012; 3 Mendez (CR49) 2019; 47 CR24 Johansson (CR8) 2013; 110 Robbins (CR22) 2023; 77 EL Watts (48017_CR2) 2023; 52 Å Johansson (48017_CR8) 2013; 110 A Knuppel (48017_CR1) 2020; 80 KR Wilson (48017_CR23) 2021; 99 S Harlid (48017_CR29) 2017; 2017 J Zhang (48017_CR37) 2022; 54 X Sun (48017_CR28) 2022; 14 48017_CR43 R Collins (48017_CR41) 2012; 379 48017_CR44 D Ochoa (48017_CR48) 2023; 51 48017_CR46 Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer. (48017_CR5) 2018; 4 D Albanes (48017_CR27) 2023; 14 C Langenberg (48017_CR40) 2023; 29 PJ Thul (48017_CR47) 2018; 27 MB Álvez (48017_CR31) 2023; 14 RS Dhindsa (48017_CR39) 2023; 622 F Martínez-Jiménez (48017_CR26) 2020; 20 K Suhre (48017_CR9) 2021; 22 K Gnanasambandan (48017_CR19) 2010; 49 PM Kolijn (48017_CR32) 2022; 139 U Menon (48017_CR4) 2021; 397 K Smith Byrne (48017_CR3) 2019; 30 L Wik (48017_CR42) 2021; 20 48017_CR36 C DeBoever (48017_CR11) 2018; 9 48017_CR16 JA Lane (48017_CR7) 2010; 46 S Dagnino (48017_CR21) 2021; 81 A Tsherniak (48017_CR17) 2017; 170 A Fry (48017_CR34) 2017; 186 CB Benton (48017_CR20) 2019; 125 KH Kim (48017_CR15) 2021; 1865 MR Munafò (48017_CR10) 2018; 553 A Gkatzionis (48017_CR12) 2023; 47 C Gerhauser (48017_CR25) 2018; 34 W Zhong (48017_CR13) 2020; 12 PA Beer (48017_CR18) 2010; 115 Z-L Chen (48017_CR52) 2019; 10 48017_CR24 UK Ballehaninna (48017_CR6) 2012; 3 BB Sun (48017_CR38) 2023; 622 R Kaaks (48017_CR33) 2015; 24 48017_CR50 P Cingolani (48017_CR45) 2012; 6 HA Robbins (48017_CR22) 2023; 77 48017_CR51 KJ Karczewski (48017_CR53) 2020; 581 C Kartsonaki (48017_CR30) 2022; 51 H Sung (48017_CR35) 2021; 71 D Mendez (48017_CR49) 2019; 47 48017_CR14
References_xml	– volume: 54 start-page: 593 year: 2022 end-page: 602 ident: CR37 article-title: Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies publication-title: Nat. Genet. doi: 10.1038/s41588-022-01051-w – volume: 80 start-page: 4014 year: 2020 end-page: 4021 ident: CR1 article-title: Circulating insulin-like growth factor-I concentrations and risk of 30 cancers: prospective analyses in UK Biobank publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-20-1281 – volume: 9 year: 2018 ident: CR11 article-title: Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study publication-title: Nat. Commun. doi: 10.1038/s41467-018-03910-9 – volume: 24 start-page: 538 year: 2015 end-page: 545 ident: CR33 article-title: Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23 publication-title: Cancer Epidemiol. Biomarkers Prev. doi: 10.1158/1055-9965.EPI-14-1107 – volume: 10 year: 2019 ident: CR52 article-title: A high-speed search engine pLink 2 with systematic evaluation for proteome-scale identification of cross-linked peptides publication-title: Nat. Commun. doi: 10.1038/s41467-019-11337-z – ident: CR16 – ident: CR51 – volume: 139 start-page: 1557 year: 2022 end-page: 1563 ident: CR32 article-title: High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis publication-title: Blood doi: 10.1182/blood.2021012890 – volume: 1865 start-page: 129834 year: 2021 ident: CR15 article-title: GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH publication-title: Biochim. Biophys. Acta Gen. Subj. doi: 10.1016/j.bbagen.2020.129834 – volume: 3 start-page: 105 year: 2012 end-page: 119 ident: CR6 article-title: The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal publication-title: J. Gastrointest. Oncol. – volume: 71 start-page: 209 year: 2021 end-page: 249 ident: CR35 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: Ca. Cancer J. Clin. doi: 10.3322/caac.21660 – volume: 47 start-page: D930 year: 2019 end-page: D940 ident: CR49 article-title: ChEMBL: towards direct deposition of bioassay data publication-title: Nucleic Acids Res. doi: 10.1093/nar/gky1075 – volume: 46 start-page: 3095 year: 2010 end-page: 3101 ident: CR7 article-title: Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2010.09.016 – volume: 14 year: 2023 ident: CR27 article-title: The blood proteome of imminent lung cancer diagnosis publication-title: Nat. Commun. doi: 10.1038/s41467-023-37979-8 – volume: 622 start-page: 339 year: 2023 end-page: 347 ident: CR39 article-title: Rare variant associations with plasma protein levels in the UK Biobank publication-title: Nature doi: 10.1038/s41586-023-06547-x – volume: 2017 start-page: 4803156 year: 2017 ident: CR29 article-title: The Metabolic syndrome, inflammation, and colorectal cancer risk: an evaluation of large panels of plasma protein markers using repeated, prediagnostic samples publication-title: Mediators Inflamm. doi: 10.1155/2017/4803156 – volume: 81 start-page: 3738 year: 2021 end-page: 3748 ident: CR21 article-title: Prospective identification of elevated circulating CDCP1 in patients years before onset of lung cancer publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-20-3454 – volume: 99 start-page: 962 year: 2021 end-page: 971 ident: CR23 article-title: Dendritic cell Flt3 – regulation, roles and repercussions for immunotherapy publication-title: Immunol. Cell Biol. doi: 10.1111/imcb.12484 – ident: CR46 – volume: 29 start-page: 1649 year: 2023 end-page: 1657 ident: CR40 article-title: Biological and functional multimorbidity—from mechanisms to management publication-title: Nat. Med. doi: 10.1038/s41591-023-02420-6 – volume: 27 start-page: 233 year: 2018 end-page: 244 ident: CR47 article-title: The human protein atlas: a spatial map of the human proteome publication-title: Protein Sci. doi: 10.1002/pro.3307 – volume: 34 start-page: 996 year: 2018 end-page: 1011.e8 ident: CR25 article-title: Molecular evolution of early onset prostate cancer identifies molecular risk markers and clinical trajectories publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.10.016 – ident: CR50 – ident: CR36 – volume: 553 start-page: 399 year: 2018 end-page: 401 ident: CR10 article-title: Robust research needs many lines of evidence publication-title: Nature doi: 10.1038/d41586-018-01023-3 – volume: 581 start-page: 434 year: 2020 end-page: 443 ident: CR53 article-title: The mutational constraint spectrum quantified from variation in 141,456 humans publication-title: Nature doi: 10.1038/s41586-020-2308-7 – volume: 115 start-page: 2891 year: 2010 end-page: 2900 ident: CR18 article-title: Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm publication-title: Blood doi: 10.1182/blood-2009-08-236596 – volume: 49 start-page: 9972 year: 2010 end-page: 9984 ident: CR19 article-title: The constitutive activation of Jak2-V617F is mediated by a π stacking mechanism involving Phe 595 and Phe 617 publication-title: Biochemistry doi: 10.1021/bi1014858 – ident: CR43 – volume: 170 start-page: 564 year: 2017 end-page: 576 ident: CR17 article-title: Defining a cancer dependency map publication-title: Cell doi: 10.1016/j.cell.2017.06.010 – volume: 125 start-page: 1855 year: 2019 end-page: 1866 ident: CR20 article-title: Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia publication-title: Cancer doi: 10.1002/cncr.31986 – volume: 51 start-page: D1353 year: 2023 end-page: D1359 ident: CR48 article-title: The next-generation Open Targets Platform: reimagined, redesigned, rebuilt publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkac1046 – volume: 22 start-page: 19 year: 2021 end-page: 37 ident: CR9 article-title: Genetics meets proteomics: perspectives for large population-based studies publication-title: Nat. Rev. Genet. doi: 10.1038/s41576-020-0268-2 – ident: CR14 – volume: 20 start-page: 100168 year: 2021 ident: CR42 article-title: Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis publication-title: Mol. Cell. Proteomics doi: 10.1016/j.mcpro.2021.100168 – volume: 14 year: 2023 ident: CR31 article-title: Next generation pan-cancer blood proteome profiling using proximity extension assay publication-title: Nat. Commun. doi: 10.1038/s41467-023-39765-y – volume: 30 start-page: 983 year: 2019 end-page: 989 ident: CR3 article-title: The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition publication-title: Ann. Oncol. doi: 10.1093/annonc/mdz121 – volume: 52 start-page: 71 year: 2023 end-page: 86 ident: CR2 article-title: Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyac124 – volume: 397 start-page: 2182 year: 2021 end-page: 2193 ident: CR4 article-title: Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(21)00731-5 – volume: 14 start-page: 3261 year: 2022 ident: CR28 article-title: Prospective proteomic study identifies potential circulating protein biomarkers for colorectal cancer risk publication-title: Cancers doi: 10.3390/cancers14133261 – volume: 379 start-page: 1173 year: 2012 end-page: 1174 ident: CR41 article-title: What makes UK Biobank special? publication-title: Lancet doi: 10.1016/S0140-6736(12)60404-8 – ident: CR44 – volume: 186 start-page: 1026 year: 2017 end-page: 1034 ident: CR34 article-title: Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population publication-title: Am. J. Epidemiol. doi: 10.1093/aje/kwx246 – volume: 110 start-page: 4673 year: 2013 end-page: 4678 ident: CR8 article-title: Identification of genetic variants influencing the human plasma proteome publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1217238110 – volume: 77 start-page: 1 year: 2023 end-page: 12 ident: CR22 article-title: Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program publication-title: Ann. Epidemiol. doi: 10.1016/j.annepidem.2022.10.014 – volume: 47 start-page: 3 year: 2023 end-page: 25 ident: CR12 article-title: Statistical methods for cis‐Mendelian randomization with two‐sample summary‐level data publication-title: Genet. Epidemiol. doi: 10.1002/gepi.22506 – volume: 20 start-page: 555 year: 2020 end-page: 572 ident: CR26 article-title: A compendium of mutational cancer driver genes publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-020-0290-x – volume: 51 start-page: 817 year: 2022 end-page: 829 ident: CR30 article-title: Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyab274 – volume: 622 start-page: 329 year: 2023 end-page: 338 ident: CR38 article-title: Plasma proteomic associations with genetics and health in the UK Biobank publication-title: Nature doi: 10.1038/s41586-023-06592-6 – volume: 6 start-page: 80 year: 2012 end-page: 92 ident: CR45 article-title: A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff publication-title: Fly doi: 10.4161/fly.19695 – volume: 12 year: 2020 ident: CR13 article-title: Whole-genome sequence association analysis of blood proteins in a longitudinal wellness cohort publication-title: Genome Med. doi: 10.1186/s13073-020-00755-0 – ident: CR24 – volume: 4 start-page: e182078 year: 2018 ident: CR5 article-title: Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2018.2078 – ident: 48017_CR46 – volume: 622 start-page: 329 year: 2023 ident: 48017_CR38 publication-title: Nature doi: 10.1038/s41586-023-06592-6 – volume: 81 start-page: 3738 year: 2021 ident: 48017_CR21 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-20-3454 – volume: 115 start-page: 2891 year: 2010 ident: 48017_CR18 publication-title: Blood doi: 10.1182/blood-2009-08-236596 – volume: 622 start-page: 339 year: 2023 ident: 48017_CR39 publication-title: Nature doi: 10.1038/s41586-023-06547-x – volume: 30 start-page: 983 year: 2019 ident: 48017_CR3 publication-title: Ann. Oncol. doi: 10.1093/annonc/mdz121 – volume: 397 start-page: 2182 year: 2021 ident: 48017_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(21)00731-5 – volume: 3 start-page: 105 year: 2012 ident: 48017_CR6 publication-title: J. Gastrointest. Oncol. – volume: 22 start-page: 19 year: 2021 ident: 48017_CR9 publication-title: Nat. Rev. Genet. doi: 10.1038/s41576-020-0268-2 – volume: 24 start-page: 538 year: 2015 ident: 48017_CR33 publication-title: Cancer Epidemiol. Biomarkers Prev. doi: 10.1158/1055-9965.EPI-14-1107 – volume: 14 year: 2023 ident: 48017_CR31 publication-title: Nat. Commun. doi: 10.1038/s41467-023-39765-y – ident: 48017_CR16 doi: 10.3389/fimmu.2021.681639 – volume: 379 start-page: 1173 year: 2012 ident: 48017_CR41 publication-title: Lancet doi: 10.1016/S0140-6736(12)60404-8 – volume: 125 start-page: 1855 year: 2019 ident: 48017_CR20 publication-title: Cancer doi: 10.1002/cncr.31986 – volume: 14 year: 2023 ident: 48017_CR27 publication-title: Nat. Commun. doi: 10.1038/s41467-023-37979-8 – ident: 48017_CR14 doi: 10.1093/ije/dyw314 – volume: 20 start-page: 100168 year: 2021 ident: 48017_CR42 publication-title: Mol. Cell. Proteomics doi: 10.1016/j.mcpro.2021.100168 – volume: 170 start-page: 564 year: 2017 ident: 48017_CR17 publication-title: Cell doi: 10.1016/j.cell.2017.06.010 – volume: 110 start-page: 4673 year: 2013 ident: 48017_CR8 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1217238110 – volume: 47 start-page: D930 year: 2019 ident: 48017_CR49 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gky1075 – ident: 48017_CR43 – ident: 48017_CR44 doi: 10.1101/2022.10.09.511476 – volume: 4 start-page: e182078 year: 2018 ident: 48017_CR5 publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2018.2078 – volume: 52 start-page: 71 year: 2023 ident: 48017_CR2 publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyac124 – volume: 51 start-page: D1353 year: 2023 ident: 48017_CR48 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkac1046 – volume: 47 start-page: 3 year: 2023 ident: 48017_CR12 publication-title: Genet. Epidemiol. doi: 10.1002/gepi.22506 – ident: 48017_CR50 – ident: 48017_CR36 doi: 10.1101/2023.11.13.23298365 – volume: 54 start-page: 593 year: 2022 ident: 48017_CR37 publication-title: Nat. Genet. doi: 10.1038/s41588-022-01051-w – volume: 80 start-page: 4014 year: 2020 ident: 48017_CR1 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-20-1281 – volume: 9 year: 2018 ident: 48017_CR11 publication-title: Nat. Commun. doi: 10.1038/s41467-018-03910-9 – ident: 48017_CR24 doi: 10.1200/EDBK_390384 – volume: 6 start-page: 80 year: 2012 ident: 48017_CR45 publication-title: Fly doi: 10.4161/fly.19695 – volume: 12 year: 2020 ident: 48017_CR13 publication-title: Genome Med. doi: 10.1186/s13073-020-00755-0 – volume: 46 start-page: 3095 year: 2010 ident: 48017_CR7 publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2010.09.016 – volume: 1865 start-page: 129834 year: 2021 ident: 48017_CR15 publication-title: Biochim. Biophys. Acta Gen. Subj. doi: 10.1016/j.bbagen.2020.129834 – volume: 99 start-page: 962 year: 2021 ident: 48017_CR23 publication-title: Immunol. Cell Biol. doi: 10.1111/imcb.12484 – volume: 51 start-page: 817 year: 2022 ident: 48017_CR30 publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyab274 – volume: 186 start-page: 1026 year: 2017 ident: 48017_CR34 publication-title: Am. J. Epidemiol. doi: 10.1093/aje/kwx246 – volume: 581 start-page: 434 year: 2020 ident: 48017_CR53 publication-title: Nature doi: 10.1038/s41586-020-2308-7 – volume: 553 start-page: 399 year: 2018 ident: 48017_CR10 publication-title: Nature doi: 10.1038/d41586-018-01023-3 – ident: 48017_CR51 – volume: 49 start-page: 9972 year: 2010 ident: 48017_CR19 publication-title: Biochemistry doi: 10.1021/bi1014858 – volume: 139 start-page: 1557 year: 2022 ident: 48017_CR32 publication-title: Blood doi: 10.1182/blood.2021012890 – volume: 20 start-page: 555 year: 2020 ident: 48017_CR26 publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-020-0290-x – volume: 2017 start-page: 4803156 year: 2017 ident: 48017_CR29 publication-title: Mediators Inflamm. doi: 10.1155/2017/4803156 – volume: 71 start-page: 209 year: 2021 ident: 48017_CR35 publication-title: Ca. Cancer J. Clin. doi: 10.3322/caac.21660 – volume: 29 start-page: 1649 year: 2023 ident: 48017_CR40 publication-title: Nat. Med. doi: 10.1038/s41591-023-02420-6 – volume: 34 start-page: 996 year: 2018 ident: 48017_CR25 publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.10.016 – volume: 27 start-page: 233 year: 2018 ident: 48017_CR47 publication-title: Protein Sci. doi: 10.1002/pro.3307 – volume: 14 start-page: 3261 year: 2022 ident: 48017_CR28 publication-title: Cancers doi: 10.3390/cancers14133261 – volume: 77 start-page: 1 year: 2023 ident: 48017_CR22 publication-title: Ann. Epidemiol. doi: 10.1016/j.annepidem.2022.10.014 – volume: 10 year: 2019 ident: 48017_CR52 publication-title: Nat. Commun. doi: 10.1038/s41467-019-11337-z
SSID	ssj0000391844
Score	2.5424736
Snippet	The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic... Abstract The availability of protein measurements and whole exome sequence data in the UK Biobank enables investigation of potential observational and genetic...
SourceID	doaj pubmedcentral proquest pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	4010
SubjectTerms	45/43 692/4028 692/499 82/81 ADAM8 protein Aged Biobanks Biological Specimen Banks Blood Blood Proteins - genetics Cancer Diagnosis Exome - genetics Exome Sequencing Female Genetic analysis Genetic Predisposition to Disease Health risks Humanities and Social Sciences Humans Incidence Leukemia Lung cancer Male Middle Aged multidisciplinary Neoplasms - blood Neoplasms - epidemiology Neoplasms - genetics Plasma proteins Prospective Studies Proteins Proteomics Risk Factors Science Science (multidisciplinary) UK Biobank United Kingdom - epidemiology
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiJZX6ENG4gZR40ds5wioVQWCEyv1ZtmOLVaAF222EvwTfi4zTrJ0eV64RKtkYs16xvY3secbQp6AWbUTCb9_pb6W0qnaeQhWfDDMqcR9kJiN_OatuljIV5ft5bVSX3gmbKQHHjvuFFZ0rkOCq-RSGWGiYawH1JGY8gA3cPZtuuZaMFXmYNFB6CKnLJlGmNNBljkBlqQaGVN0rXZWokLY_zuU-ethyZ92TMtCdH6H3J4QJH0-ar5PbsR8QG6ONSW_3iXfxtTbkr5ECwsD5h1TPEJOp-I6FIAqDWjuNcVz70VuTrmkLvc0fll9wl9IWBIHukoU_pagYbkOpdzX3PQyD0W-tI5S3dTuQJeZAraki9cUVPMuf7hHFudn715e1FP5hTq0km1qxCK8DwCwnBGNDJr1USnDpXNJQHcA0vK60V45rgsQCIBNWqSgcxyDbnGf7OVVjg8JVTL2uo2sR_yWPMC8YGDNNLxTLGmhKsJmU9gwcZNjiYyPtuyRC2NH81kwny3ms_DO0-07n0dmjr9Kv0ALbyWRVbvcAF-zk6_Zf_laRY5m_7DTUB8sUqZx2QrZVeTx9jEMUtx5cTmurkYZ00mAYhV5MLrTVhMBESPuh1bE7Djajqq7T_LyfSECR7ZYJRivyLPZJ3_o9ee-ePQ_-uKQ3OI4mJDItj0ie5v1VTwGfLbxJ2UofgeSFzEB priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB6VIiQuiDcpBRmJGwTqR2zngBAgqgoEJ1bqzXIcB1aUhCZbqf0n_FxmnGTRwtLLarUZW2PPzPpz7PkG4Cma1XjZ0Puvps6V8jr3FW5WqmC5142ogqJs5E-f9dFCfTgujndgLnc0TeCwdWtH9aQW_cmL89OL1xjwr8aUcftyUCnccbXJiQzF5PoKXE3nRXSVb4L76Z9ZlrihUVPuzPamG-tTovHfhj3_vUL51zlqWp4Ob8KNCVeyN6Mj3IKd2N6Ga2OlyYs78GtMyE1JTSxxM1A2MqOL5WwqucMQvrJATtAzug2f5OZETObbmsXz7gd9IxqTOLCuYTgsycKyD6kI2Nz1sh2SfOqdpMqp34EtW4aIky0-MlSt8u33u7A4fP_l3VE-FWXIQ6H4KieEIuqAsMtbeaCC4XXU2grlfSNxOhB_VebAVNoLk-BBQMRSEDGdF7QVl_dgt-3a-ACYVrE2ReQ1obqmQvAXLK6kVpSaN0bqDPhsChcmxnIqnHHi0sm5tG40n0PzuWQ-h22erdv8HPk6LpV-SxZeSxLXdvqh67-6KXQdai9MaPBT4QistNFyXiPubbiuEPBmsD_7h5v91xGRmlCFVGUGT9aPMXTpPMa3sTsbZWypEKBlcH90p7UmEveRdEqagd1wtA1VN5-0y2-JHpw4ZLXkIoPns0_-0ev_c7F3-TAewnVBYULEtcU-7K76s_gI8diqepyC7Dd9EC3U priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LixQxEC7WFcGL-LZ1lQjetHHy6CRz1MFlUfTkwN5Ckk7roHbL9Cy4_2R_rlXph4yugpdhmK6E6q6qyZdO1VcAz9CsxsuG3n81damU16UPuFkJ0XKvGxGiomrk9x_0yVq9Pa1OD0BMtTA5aT9TWua_6Sk77GWvckjjilIS4Ykp9RW4ao2syKtXejW_VyHGc6vUWB-zkPaSoXtrUKbqvwxf_pkm-dtZaV6Cjm_CjRE7sleDtrfgILW34drQTfL8DlwMRbe5cIll_gWqOGaUPM7GtjoMISqLZOgto4z3LDcVWzLf1iz96L7RN6IqST3rGoa3JVncbGNu9DVNvWn7LJ9nJ6nlOG_PNi1DVMnW7xiqFnz75S6sj998XJ2UY-OFMlaK70pCIaKOCK28lQsVDa-T1lYo7xuJjwMxVjALE7QXJkOAiKikIvI5L2i7Le_BYdu16QEwrVJtqsRrQm5NQIAXLa6WViw1b4zUBfDJFC6OrOTUHOOry6fj0rrBfA7N57L5HI55Po_5PnBy_FP6NVl4liQ-7fxDt_3kRv9yqL0wscFPhXdgpU2W8xqxbcN1QFBbwNHkH24M8t4RWZpQlVTLAp7OlzE86czFt6k7G2TsUiEIK-D-4E6zJhL3inQSWoDdc7Q9VfevtJvPmQKceGK15KKAF5NP_tLr78_i4f-JP4LrgsKGyGqrIzjcbc_SY8Rgu_AkB91PztAoew priority: 102 providerName: Springer Nature
Title	Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank
URI	https://link.springer.com/article/10.1038/s41467-024-48017-6 https://www.ncbi.nlm.nih.gov/pubmed/38750076 https://www.proquest.com/docview/3055245349 https://www.proquest.com/docview/3055894223 https://pubmed.ncbi.nlm.nih.gov/PMC11096312 https://doaj.org/article/55127cf5124246838e811d932f16b540
Volume	15
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwEB7ttkLigngTWCojcYNom9ix3QNC3WrLqmgrBFTqLXIcByogWZquBP-En8uM81iVx16sKJ5YdmZsf37MNwDPUa3K8IL2v4o8FMLI0GS4WMmsjows4swK8kY-X8qzlVisk_UBLDtfGLpW2Y2JfqDOK0t75MfETBWLhIvJ64vvIUWNotPVLoSGaUMr5K88xdghDHFITsYDGJ6cLt-973ddiA9dC9F6z4y5Pq6FHytwqgqJSUWFcm-G8kT-_0Kff1-i_OMk1U9Q89twq0WWbNqYwh04cOVduNHEmvx5D341LrnerYl5dgbyR2Z0tZy1QXcYAlhmyQy2jO7De7nOFZOZMmfuR_WNnojIxNWsKhg2izO72VofBqwrelPWXt6XTlKTttyabUqGmJOt3jKsWmbKL_dhNT_9ODsL27AMoU1EtAsJo8S5ReBlNB8Lq6LcSaljYUzB8XcgAsvUWGXSxMoDBIs6SYiazsS0GOcPYFBWpXsETAqXq8RFOeG6IkP4ZzUqTscTGRWKywCiThWpbTnLKXTG19SfnXOdNupLUX2pV1-K37zov7loGDuulT4hDfeSxLbtX1TbT2nbeVOsfaxsganAFmiunY6iHJFvEckMIW8AR519pO0QUKdXBhvAsz4bOy-dyJjSVZeNjJ4IhGgBPGzMqa8Jx5UknZMGoPcMba-q-znl5rMnCCcWWcmjOICXnU1e1ev__-Lx9c14Ajdj6iZEXZscwWC3vXRPEZHtshEcqrXCVM_fjGA4nS4-LEZt18O3Mzkb-b0OTM-F_g3bQTc5
linkProvider	ProQuest
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrRBcEG8CBYwEJ4ja2I7jPVSIQqst264QaqXejOM4sAKSstkK-k_4Nfw2Zpxkq-XRWy-r1WbiODvjmc-P-QbgKao1s6Kk9a-yiKW0KrY5TlZypxOrSp47SdnI-xM1OpRvj9KjFfjV58LQscreJwZHXdSO1sjXiZmKy1TI4cvjbzFVjaLd1b6Ehu1KKxSbgWKsS-wY-9PvOIVrNnffoL6fcb6zffB6FHdVBmKXymQeU8jlhUMcYTXO7V2WFF4pzaW1pSicR0CRZxtZrizPQrxz-IiUmNYsp7mlwHYvwaqkBZQBrG5tT969X6zyEP-6lrLL1tkQer2RwTdhaIyJuSWL1VJEDIUD_oV2_z60-cfObQiIO9fhWodk2avW9G7Aiq9uwuW2tuXpLfjZpgCHNCoW2CAo_5nRUXbWFflhCJiZI7ObMTp_H-T61E9mq4L5H_VX-kbEKb5hdcnwtQRz05kLZcf6pqdVE-RD6yQ17Npt2LRiiHHZ4Zhh13Jbfb4NhxeioDswqOrK3wOmpC-y1CcF4cgyR7jpNMZuzYcqKTOhIkh6VRjXcaRTqY4vJuzVC21a9RlUnwnqM3jP88U9xy1DyLnSW6ThhSSxe4cf6tlH0zkLg73nmSvxU-IbaKG9TpICkXaZqBzNLIK13j5M53IaczZAIniyuIzOgnaAbOXrk1ZGDyVCwgjutua06InAmSvty0aglwxtqavLV6rpp0BITqy1SiQ8ghe9TZ716___xf3zX-MxXBkd7O-Zvd3J-AFc5TRkiDY3XYPBfHbiHyIanOePuiHH4MNFj_Lfnxlq9w
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKEYgL4lkWChgJTrBK_VjbOSAElKglUHEgUm7G6_VCBOyWbCroP-G38OuY8T6q8OitlyjKzlp2Zjzz-THfEPIQ1KqdKHH_qyxSKZ1KXQ6Lldwb5lTJcy8xG_ntgdqbydfzbL5BfvW5MHitsveJ0VEXtcc98hEyU3GZCTkeld21iHe7k2eH31KsIIUnrX05jdZEpuH4Oyzfmqf7u6DrR5xPXr1_uZd2FQZSn0m2SjHc8sIDhnAG1vVesyIoZbh0rhSFDwAmcr2jc-W4jrHOQ_jNkGXNcVxXCmj3HDmvhZRYNkLP9bC_g8zrRsouT2dHmFEjo1eCoJgiZ4tO1VosjCUD_oVz_76u-ceZbQyFkyvkcodh6fPW6K6SjVBdIxfaqpbH18nPNvk3JlDRyAOBmc8UL7HTrrwPBahMPRrckuLN-yjXJ31SVxU0_Ki_4jekTAkNrUsKwxLUL5Y-Fhzrm15UTZSPraPUuGu3oYuKArqlsymFruWu-nyDzM5EPTfJZlVX4RahSoZCZ4EViCDLHICmNxC1DR8rVmqhEsJ6VVjfsaNjkY4vNp7SC2Nb9VlQn43qs_DO4-Gdw5Yb5FTpF6jhQRJ5veMP9fKj7dyEhd5z7Uv4lDACI0wwjBWAsUumcgDXCdnu7cN2zqaxJ1MjIQ-Gx-Am8OzHVaE-amXMWAIYTMhWa05DTwSsWfFENiFmzdDWurr-pFp8ilTkyFerBOMJedLb5Em__v9f3D59GPfJRZjb9s3-wfQOucRxxiBfbrZNNlfLo3AXYOAqvxfnGyUfznqC_waW3GiT
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identifying+proteomic+risk+factors+for+cancer+using+prospective+and+exome+analyses+of+1463+circulating+proteins+and+risk+of+19+cancers+in+the+UK+Biobank&rft.jtitle=Nature+communications&rft.au=Papier%2C+Keren&rft.au=Atkins%2C+Joshua+R&rft.au=Tong%2C+Tammy+Y.+N&rft.au=Gaitskell%2C+Kezia&rft.date=2024-05-15&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=15&rft.issue=1&rft.spage=4010&rft_id=info:doi/10.1038%2Fs41467-024-48017-6&rft.externalDBID=HAS_PDF_LINK
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon